首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1426497

即時PCR、數位 PCR、端點 PCR 2024 年全球市場報告

Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024

出版日期: 2024年02月12日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

即時PCR、數位 PCR 和終點 PCR 的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 9.4% 的複合年成長率 (CAGR) 成長至 549.5 億美元。預測期內的預期成長可歸因於分子診斷的擴展、傳染病檢查的成長、基因檢測需求的增加、調查和法醫學的市場滲透以及快速照護現場PCR 解決方案的採用。預測期內預計的主要趨勢包括數位化驗的出現、多重 PCR 的進步、向數位 PCR 技術的遷移、高通量系統的自動化以及 PCR 平台的小型化。

感染疾病的預期成長預計將推動即時PCR、數位 PCR 和端點 PCR 市場的成長。利用PCR技術可以有效對抗細菌、病毒、真菌、寄生蟲等病原微生物生長引起的感染疾病。即時PCR、數位PCR和終點PCR在定量特定病原體或其遺傳物質、監測疾病進展以及快速診斷HIV、肝炎、呼吸道病毒和結核病等感染疾病方面發揮重要作用。例如，聯合國愛滋病規劃署報告稱，到 2022 年，美國愛滋病毒感染者人數將增至 3,900 萬人。這比 2020 年的 3,770 萬人增加了 3.17%，2022 年報告的新愛滋病毒感染人數約為 130 萬人。美國疾病管制與預防中心指出，結核病病例數將從 2021 年的 7,874 例增加到 2022 年的 8,300 例。因此，感染疾病發生率的增加正在推動 PCR 市場的成長。

由於慢性病的增加，即時PCR、數位 PCR 和終點 PCR 的市場預計將擴大。慢性疾病通常會持續很長時間並隨著時間的推移而惡化，這使得它們成為 PCR 應用的重要焦點。即時PCR透過檢測與癌症、糖尿病和病毒感染等疾病相關的特定 DNA 或 RNA 標記物，有助於早期、準確地診斷慢性疾病。世界衛生組織報告稱，全球每年有4,100萬人死亡，其中74%死於非傳染性疾病，其中1,790萬人死於心血管疾病，1,790萬人死於癌症，930萬人死亡，410萬人死於慢性病。呼吸道疾病，以及 200 萬人死於糖尿病。因此，慢性病盛行率的增加已成為即時PCR、數位 PCR 和終點 PCR 市場的主要驅動力。

全球即時PCR、數位 PCR、端點 PCR 市場，依產品、效能和預測細分，2018-2023、2023-2028、2033
裝置
耗材和試劑
軟體和服務
全球即時PCR、數位 PCR、端點 PCR 市場，按技術、性能和預測細分，2018-2023、2023-2028、2033
定量的
終點聚合酵素鏈鎖反應(PCR)
數位的
全球即時PCR、數位 PCR、端點 PCR 市場，按應用細分、實際和預測，2018-2023、2023-2028、2033
臨床
研究
法醫學
其他用途
全球即時PCR、數位 PCR、端點 PCR 市場、最終用戶細分、性能和預測，2018-2023、2023-2028、2033
醫院
診斷實驗室
製藥
生物技術
合約研究組織

第 7 章區域與國家分析

全球即時PCR、數位 PCR、端點 PCR 市場，按地區、實際和預測，2018-2023、2023-2028、2033
全球即時PCR、數位 PCR、端點 PCR 市場，按國家、實際和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

即時PCR、數位PCR和端點PCR市場的競爭形勢
即時PCR、數位PCR、端點PCR市場公司概況
- F. Hoffmann La Roche Ltd.
- Merck &Co. Inc.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation

第31章其他大型創新公司

Becton Dickinson and Co.
GE HealthCare Technologies Inc.
Agilent Technologies Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
QIAGEN NV
Eppendorf Group
Promega Corporation
Meridian Bioscience Inc.
Takara Bio Inc.
Cole-Parmer Instrument Company LLC
Bioneer Corporation
Enzo Life Sciences Inc.
Analytik Jena AG
Fluidigm Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r13509

Real-time PCR (polymerase chain reaction), digital PCR, and endpoint PCR are distinct techniques in molecular biology and genetic analysis employed for amplifying and analyzing DNA samples. Real-time PCR is a laboratory technique used to amplify and quantify DNA or RNA molecules. Digital PCR is the third generation of PCR that enables precise quantification by segregating a sample into numerous isolated compartments. Endpoint PCR, also known as conventional PCR, is a fundamental molecular biology technique used to amplify a specific DNA sequence from a sample. These PCR techniques are utilized in various clinical applications, including bacteria detection, DNA fingerprinting, and genetic disorder diagnosis.

The main products associated with real-time PCR, digital PCR, and endpoint PCR include instruments, consumables and reagents, software, and services. Instruments refer to devices, tools, or equipment designed for measurement, analysis, manipulation, or control of physical, chemical, or biological phenomena. Various technologies, such as quantitative, endpoint PCR, and digital PCR, are used for clinical, research, forensic, and other applications, with different end-users including hospitals, diagnostic labs, pharmaceutical and biotechnology companies, and contract research organizations.

The real-time PCR, digital PCR and end-point PCR market research report is one of a series of new reports from The Business Research Company that provides real-time PCR, digital PCR and end-point PCR market statistics, including real-time PCR, digital PCR and end-point PCR industry global market size, regional shares, competitors with a real-time PCR, digital PCR and end-point PCR market share, detailed real-time PCR, digital PCR and end-point PCR market segments, market trends and opportunities, and any further data you may need to thrive in the real-time PCR, digital PCR and end-point PCR industry. This real-time PCR, digital PCR and end-point PCR market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $35.11 billion in 2023 to $38.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The increase observed in the historical period can be attributed to the standardization of PCR protocols, the role of PCR techniques in personalized medicine, their contribution to drug discovery and development, and the adoption of these techniques in forensic and paternity testing.

The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to $54.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the forecast period can be attributed to the expansion of molecular diagnostics, the growth in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, and the adoption of rapid point-of-care PCR solutions. Major trends expected in the forecast period involve the emergence of digital assays, advancements in multiplex PCR, a shift towards digital PCR technology, the automation of high-throughput systems, and the miniaturization of PCR platforms.

The anticipated rise in infectious diseases is set to drive the growth of the real-time PCR, digital PCR, and end-point PCR markets. Infectious diseases, caused by the proliferation of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, can be effectively addressed using PCR technologies. Real-time PCR, digital PCR, and end-point PCR play crucial roles in quantifying specific pathogens or their genetic material, monitoring disease progression, and swiftly diagnosing infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, UNAIDS reported a global increase in the population living with HIV to 39 million in 2022, representing a 3.17% rise from 37.7 million in 2020, with approximately 1.3 million new HIV infections reported in 2022. Moreover, in the United States, the Centers for Disease Control and Prevention noted a rise in tuberculosis cases to 8,300 in 2022 from 7,874 in 2021. Thus, the escalating incidence of infectious diseases is a driving force behind the growth of the PCR markets.

The growth of chronic diseases is poised to propel the real-time PCR, digital PCR, and end-point PCR markets. Chronic diseases, persistent over an extended period and often worsening over time, are a significant focus for PCR applications. Real-time PCR aids in the early and accurate diagnosis of chronic conditions by detecting specific DNA or RNA markers associated with diseases such as cancer, diabetes, and viral infections. The World Health Organization reported 41 million deaths globally annually, with 74% attributed to non-communicable diseases, including 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the increasing prevalence of chronic diseases is a key driver for the real-time PCR, digital PCR, and end-point PCR markets.

A potential challenge lies in the declining demand for PCR testing for COVID-19, which may restrict market growth. The real-time RT-PCR test, commonly used for COVID-19 detection, faces challenges such as false-negative and false-positive results due to various factors. The declining nationwide rate of PCR testing, as reported in Australia with a daily average dropping from approximately 280,220 tests to 250,000 tests, may impact the market negatively. Consequently, the decreasing demand for PCR testing for COVID-19 poses a hindrance to the growth of the real-time PCR, digital PCR, and end-point PCR markets.

Key players in the real-time PCR, digital PCR, and end-point PCR markets are actively pursuing the development of innovative products, leveraging advanced technologies such as digital polymerase chain reaction (dPCR). This cutting-edge biotechnological refinement of conventional PCR methods enables the direct quantification and clonal amplification of nucleic acid strands, encompassing DNA, cDNA, or RNA. Notably, major companies are at the forefront of adopting dPCR technology to gain a deeper understanding of patients' conditions, whether related to cancer, genetic diseases, or infections. An illustrative example is Roche Diagnostics, a prominent US-based manufacturer of medicines and medical devices, which unveiled the next-generation Digital LightCycler System in August 2022. Specifically designed for the early detection and treatment of various chronic and genetic disorders, this advanced system introduces automation to workflow and data management. It eliminates the need for external calculations, software, and processors. Boasting three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes, the Digital LightCycler System ensures high sensitivity and precision. This addition enhances Roche's diagnostic platforms, offering advanced technology, clinical applications, customization and flexibility, along with streamlined workflow automation.

In June 2021, Hologic Inc., a US-based medical technology company, completed the acquisition of Mobidiag Oy Ltd. for a substantial $795 million. This acquisition is positioned to fortify and expand Hologic's diagnostic businesses globally, leveraging Mobidiag's expertise in providing multiplex capability, particularly in fast-growing acute care adjacencies. The collaboration between the two companies aims to offer a high-throughput point-of-care growth platform, facilitating rapid treatment decisions during patient diagnosis. Mobidiag Oy Ltd., headquartered in Finland, specializes in the development and marketing of PCR-based tests for infectious diseases, including high-impact areas such as COVID-19, influenza, and antibiotic-resistant bacteria.

Major companies operating in the real-time pcr, digital pcr and end-point pcr market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time pcr, digital pcr and end-point pcr market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the real-time pcr, digital pcr and end-point pcr market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The real-time PCR, digital PCR, and end-point PCR market include revenues earned by entities by providing services such as quantitative analysis, real-time monitoring, high sensitivity and specificity, gene expression analysis, absolute quantification, rare event detection, qualitative detection, and molecular cloning. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time PCR, digital PCR, and end-point PCR market also include sales of thermal cyclers, fluorescent probes, quantitative data output, standard curves, real-time PCR reagents, partitioning chips or plates, digital PCR instruments, and PCR master mixes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on real-time PCR, digital PCR and end-point PCR market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for real-time pcr, digital pcr and end-point pcr? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The real-time pcr, digital pcr and end-point pcr market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Instruments; Consumables And Reagents; Software And Services
2) By Technology: Quantitative; End-Point Polymerase Chain Reaction (PCR); Digital
3) By Applications: Clinical; Research; Forensic; Other Applications
4) By End User: Hospital; Diagnostic Labs; Pharma; Biotech; Contract Research Organizations
Companies Mentioned: F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Real-Time PCR, Digital PCR And End-Point PCR Market Characteristics

3. Real-Time PCR, Digital PCR And End-Point PCR Market Trends And Strategies

4. Real-Time PCR, Digital PCR And End-Point PCR Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Real-Time PCR, Digital PCR And End-Point PCR Market Size and Growth

5.1. Global Real-Time PCR, Digital PCR And End-Point PCR Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Real-Time PCR, Digital PCR And End-Point PCR Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Real-Time PCR, Digital PCR And End-Point PCR Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Real-Time PCR, Digital PCR And End-Point PCR Market Segmentation

6.1. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Consumables And Reagents
Software And Services
6.2. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Quantitative
End-Point Polymerase Chain Reaction (PCR)
Digital
6.3. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinical
Research
Forensic
Other Applications
6.4. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital
Diagnostic Labs
Pharma
Biotech
Contract Research Organizations

7. Real-Time PCR, Digital PCR And End-Point PCR Market Regional And Country Analysis

7.1. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market

8.1. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Real-Time PCR, Digital PCR And End-Point PCR Market

9.1. China Real-Time PCR, Digital PCR And End-Point PCR Market Overview
9.2. China Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Real-Time PCR, Digital PCR And End-Point PCR Market

10.1. India Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Real-Time PCR, Digital PCR And End-Point PCR Market

11.1. Japan Real-Time PCR, Digital PCR And End-Point PCR Market Overview
11.2. Japan Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Real-Time PCR, Digital PCR And End-Point PCR Market

12.1. Australia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market

13.1. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market

14.1. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market Overview
14.2. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market

15.1. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market Overview
15.2. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Real-Time PCR, Digital PCR And End-Point PCR Market

16.1. UK Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Real-Time PCR, Digital PCR And End-Point PCR Market

17.1. Germany Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Real-Time PCR, Digital PCR And End-Point PCR Market

18.5. France Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Real-Time PCR, Digital PCR And End-Point PCR Market

19.9. Italy Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Real-Time PCR, Digital PCR And End-Point PCR Market

20.13. Spain Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market

21.1. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market Overview
21.2. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Real-Time PCR, Digital PCR And End-Point PCR Market

22.1. Russia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Real-Time PCR, Digital PCR And End-Point PCR Market

23.1. North America Real-Time PCR, Digital PCR And End-Point PCR Market Overview
23.2. North America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Real-Time PCR, Digital PCR And End-Point PCR Market

24.1. USA Real-Time PCR, Digital PCR And End-Point PCR Market Overview
24.2. USA Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Real-Time PCR, Digital PCR And End-Point PCR Market

25.1. Canada Real-Time PCR, Digital PCR And End-Point PCR Market Overview
25.2. Canada Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Real-Time PCR, Digital PCR And End-Point PCR Market

26.1. South America Real-Time PCR, Digital PCR And End-Point PCR Market Overview
26.2. South America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market

27.1. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market

28.1. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market Overview
28.2. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Real-Time PCR, Digital PCR And End-Point PCR Market

29.1. Africa Real-Time PCR, Digital PCR And End-Point PCR Market Overview
29.2. Africa Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Landscape And Company Profiles

30.1. Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Landscape
30.2. Real-Time PCR, Digital PCR And End-Point PCR Market Company Profiles
- 30.2.1. F. Hoffmann La Roche Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Danaher Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Real-Time PCR, Digital PCR And End-Point PCR Market Other Major And Innovative Companies

31.1. Becton Dickinson and Co.
31.2. GE HealthCare Technologies Inc.
31.3. Agilent Technologies Inc.
31.4. bioMerieux S.A.
31.5. Bio-Rad Laboratories Inc.
31.6. QIAGEN N.V.
31.7. Eppendorf Group
31.8. Promega Corporation
31.9. Meridian Bioscience Inc.
31.10. Takara Bio Inc.
31.11. Cole-Parmer Instrument Company LLC
31.12. Bioneer Corporation
31.13. Enzo Life Sciences Inc.
31.14. Analytik Jena AG
31.15. Fluidigm Corporation

32. Global Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Benchmarking

33. Global Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Real-Time PCR, Digital PCR And End-Point PCR Market

35. Real-Time PCR, Digital PCR And End-Point PCR Market Future Outlook and Potential Analysis

35.1 Real-Time PCR, Digital PCR And End-Point PCR Market In 2028 - Countries Offering Most New Opportunities
35.2 Real-Time PCR, Digital PCR And End-Point PCR Market In 2028 - Segments Offering Most New Opportunities
35.3 Real-Time PCR, Digital PCR And End-Point PCR Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies